![](https://investorshub.advfn.com/uicon/48355.png?cb=1551739062)
Monday, October 11, 2021 9:25:45 AM
Clinicians at Birmingham Orthopedic and Sports Specialists recently conducted a randomized, double-blind study to evaluate the safety and effectiveness of the NanoVibronix PainShield. Patients in the study were being treated by an orthopedic surgeon for lateral epicondylitis, more commonly known as tennis elbow, a swelling or tearing of the tendons in the arm. It is characterized by a pain or ache on the outside of the arm where the forearm meets the elbow. All patients in the study had symptoms of pain and point tenderness at the beginning of the study and had been following customary treatment guidance, which failed to provide pain relief. Conversely, at the conclusion of the study, 91% of the patients in the PainShield treatment group had complete or partial resolution of symptoms. Patients used PainShield in conjunction with over-the-counter medication, as needed, but without the benefit of opioid-based prescription medication.
Brian Murphy, CEO of Nanovibronix, stated, "Results of the Birmingham study further reinforce that PainShield is safe, easy-to-use and highly effective in treating soft tissue pain. Patients in the study who wore our device reported marked reduction in pain and when combined with over-the-counter, anti-inflammatory medications, those same patients reported a complete resolution of symptoms within 10 days."
Dr. David Lemak, MD, Lead Investigator of the Birmingham Study, added, "Patient outcomes were markedly improved with the use of PainShield and importantly, no patients returned with signs or symptoms of an exacerbation. Most encouraging are the results we were able to achieve for our patients without the use of prescription opioid medications, which can often lead to prolonged use and addiction."
New York Yankees and Duke Basketball
Recent NAOV News
- NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan • Business Wire • 05/22/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 08:05:32 PM
- NanoVibronix Issues Letter to Stockholders • Business Wire • 05/16/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 05:25:53 PM
- NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield • Business Wire • 05/14/2024 12:30:00 PM
- NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award • Business Wire • 05/01/2024 12:00:00 PM
- NanoVibronix Issues Letter to Stockholders • Business Wire • 04/09/2024 12:30:00 PM
- NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield • Business Wire • 03/28/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 10:32:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2024 12:19:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2024 12:18:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2024 12:17:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2024 12:15:46 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:45:41 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/17/2024 09:31:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:30:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 09:30:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 09:45:11 PM
- NanoVibronix Featured in Your Bladder Health Magazine • Business Wire • 12/06/2023 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:45:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:45:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:45:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:45:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:45:02 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 09:45:16 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM